Rankings
▼
Calendar
IOBT
IO Biotech, Inc.
$18M
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$11M
EPS (Diluted)
$-60.66
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$131,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$11M
Stockholders' Equity
-$1M
Cash & Equivalents
$8M
← Q1 2020
All Quarters
IOBT FY 2019 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena
